Androgen-induced rhox homeobox genes modulate the expression of AR-regulated genes by Hu, Z. et al.
 
 
 
 
 
 
 
Hu, Z. and Dandekar, D. and O'Shaughnessy, P.J. and De Gendt, K. and 
Verhoeven, G. and Wilkinson, M.F. (2010) Androgen-induced rhox 
homeobox genes modulate the expression of AR-regulated genes. 
Molecular Endocrinology, 24 (1). pp. 60-75. ISSN 0888-8809 
 
http://eprints.gla.ac.uk/30445/ 
 
Deposited on: 03 June 2010 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
Androgen-Induced Rhox Homeobox Genes Modulate the Expression 
of AR-Regulated Genes  
 
Abbreviated title: Rhox5-Regulated Genes 
 
Zhiying Hu, Dineshkumar Dandekar§, Peter J. O'Shaughnessy, Karel De Gendt, Guido 
Verhoeven, and Miles F. Wilkinson  
 
Department of Reproductive Medicine (M.F.W.), The University of California, San Diego, 
CA 92093; Department of Biochemistry & Molecular Biology (Z.H., D.D., M.F.W.), 
University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; The Institute of 
Comparative Medicine (P.J.O.), University of Glasgow Veterinary School, Bearsden Rd, 
Glasgow G61 1QH, UK; Laboratory for Experimental Medicine and Endocrinology (K.D.G., 
G.V.), Catholic University of Leuven, Leuven, Belgium. 
 
Address correspondence to: Miles F. Wilkinson, Department of Reproductive Medicine, 
University of California, San Diego, 9500 Gilman Drive, MC 0864, La Jolla, CA 92093-0864 
Tel.: 858-822-4819; Fax: 858-822-1966; E-mail: mfwilkinson@ucsd.edu 
 
§ present address: Fox Chase Cancer Center, Philadelphia, PA 19111  
 
 
 Key words:  Rhox5, homeobox, Sertoli cells, androgen receptor, transcription  
 
This work was supported by National Institutes of Health grant HD45595.   
 
DISCLOSURE STATEMENT: The authors have nothing to disclose. 
ABSTRACT 
Rhox5, the founding member of the reproductive homeobox on the X chromosome (Rhox) 
gene cluster, encodes a homeodomain-containing transcription factor that is selectively 
expressed in Sertoli cells, where it promotes the survival of male germ cells.  To identify 
Rhox5-regulated genes, we generated 15P-1 Sertoli cell clones expressing physiological levels 
of Rhox5 from a stably transfected expression vector.  Microarray analysis identified many 
genes altered in expression in response to Rhox5, including those encoding proteins 
controlling cell cycle regulation, apoptosis, metabolism, and cell-cell interactions.  Fifteen of 
these Rhox5-regulated genes were chosen for further analysis.  Analysis of Rhox5-null male 
mice indicated that at least 9 of these are Rhox5-regulated in the testes in vivo.  Many of 
them have distinct postnatal expression patterns and are regulated by Rhox5 at different 
postnatal time points.  Most of them are expressed in Sertoli cells, indicating that they are 
candidates to be directly regulated by Rhox5.  Transfection analysis with expression vectors 
encoding different mouse and human Rhox family members revealed that the regulatory 
response of a subset of these Rhox5-regulated genes is both conserved and redundant.  Given 
that Rhox5 depends on AR for expression in Sertoli cells, we examined whether some Rhox5-
regulated genes are also regulated by androgen receptor (AR).  We provide several lines of 
evidence that this is the case, leading us to propose that RHOX5 serves as a key intermediate 
transcription factor that directs some of the actions of AR in the testes.  
 
Introduction 
Homeobox genes encode transcription factors harboring a 60 amino-acid DNA-binding motif 
called a homeodomain (HD).  These transcription factors govern key embryonic 
developmental processes, including body-axis formation, organogenesis, and limb 
development (1).  While the roles of homeobox genes in embryonic development have been 
intensely studied for over two decades, their functions in controlling post-embryonic 
developmental events have only begun to be examined.  Homeobox genes are good 
candidates to control post-embryonic events, as many homeobox genes are expressed during 
postnatal development and in adult tissues.  Indeed, mouse knockout studies have shown that 
the HoxA9, Hoxc13, and Pdx1 homeobox genes are crucial for hematopoiesis, hair growth, 
and gut homeostasis, respectively (2-4).   
 Another post-embryonic process likely to be controlled by homeobox genes is 
spermatogenesis.  This idea is supported by the fact that over 50 of the ~200 known mouse 
homeobox genes are expressed in the testis and other male reproductive organs (5-12).  
While this suggests a role for homeobox transcription factors in male reproduction, the 
functions of most homeobox transcription factors in the postnatal and adult male reproductive 
tract are not yet clear, as efforts to elucidate their roles using knockout mice have been 
clouded by putative functional redundancies and embryonic lethality (6).  These efforts have 
identified some homeobox genes that control the formation of the male reproductive tract 
during embryogenesis, but the identity of homeobox genes that have roles in the male 
reproductive tract after birth have remained largely obscure (5, 12-14). 
To our knowledge, the only mammalian homebox gene demonstrated to have a role in 
spermatogenesis is Rhox5 (previously known as Pem), the founding member of the 
reproductive homoeobox genes on the X chromosome (Rhox) gene family (7).  All the 
members of the Rhox gene family form a tandem array on the X chromosome in mammals.  
The mouse Rhox gene cluster contains 33 members, and thus is the largest homeobox gene 
cluster known in any species (7-11, 15).  Virtually all of the Rhox genes are selectively 
expressed in reproductive tissues and the placenta, suggesting that they encode transcription 
factors devoted to regulating gametogenesis and embryogenesis (7).  
Rhox5 was first identified in a search for genes differentially expressed between two 
related T-lymphoma cell clones that exhibited marked differences in developmental status and 
tumorigenicity (16).  Rhox5 was initially of interest because it was found to be selectively 
expressed in T-cell lymphomas, not normal T cells, and also in a wide variety of other tumor 
cells of diverse developmental and tissue origins (17).  Later investigations revealed that 
Rhox5 encodes a tumor antigen (18), interacts with protein involved in tumorigenesis (19, 20), 
and its expression is induced by the proto-oncogene Ras (21, 22).  While these studies have 
suggested the possibility that Rhox5 has a role in tumorigenesis, its precise role in malignancy 
has not yet been determined.  Other studies have focused on Rhox5’s normal expression 
pattern and biological roles.  Rhox5 is normally expressed in the early mouse embryo in a 
developmentally regulated manner (23), and is later expressed in placenta (24, 25) and in both 
male and female germ cells in developing fetal gonads (26, 27).  In neonatal and adult mice 
and rats, Rhox5 expression is primarily confined to somatic cells in the testis, epididymis, and 
ovary (28, 29).  In the testis, its expression is restricted to Sertoli cells, where it is expressed 
in a stage-specific manner during the seminiferous epithelial cycle by an androgen- and 
androgen receptor (AR)-dependent mechanism (30, 31).  
The expression of Rhox5 in somatic cells in the male reproductive tract is crucial for 
normal spermatogenesis and sperm maturation.  Targeted mutation of Rhox5 in male mice 
leads to subfertility, marked by increased germ-cell apoptosis, reduced sperm number, and 
reduced sperm motility (7).  Rhox5-null mice exhibit an increased frequency of apoptotic 
germ cells in seminiferous epithelial cycle stages that normally contain dying germ cells 
(stages I to IV and stage XII) and they also have apoptotic germ cells in stages that normally 
lack dying germ cells (stages V to XI).  Rhox5 is unlikely to act directly on germ cells to 
control germ cell survival and motility, as it is not detectably expressed in germ cells but 
instead is expressed in Sertoli cells, the nurse cells in intimate contact with germ cells (29, 30).  
This suggests a model in which Rhox5 functions in spermatogenesis by virtue of its ability to 
regulate genes encoding Sertoli cell secreted and cell surface proteins that, in turn, control key 
events in germ cells, including their differentiation and survival (32-34).   
To begin to address the molecular mechanisms by which Rhox5 helps drive 
spermatogenesis, we used transcriptional profiling to identify genes regulated by 
physiological levels of Rhox5 in 15P-1 cells, a well-established Sertoli cell line (35-37).  
This genome-wide analysis led to the discovery of many Rhox5-regulated genes, a large 
proportion of which encode cell-surface proteins.  Many of these were expressed in Sertoli 
cells, which was of interest because such genes could mediate Rhox5-induced signals that 
impinge on germ cells.  Also identified were Rhox5-regulated genes encoding other kinds of 
proteins, including secreted factors, transcription factors, and metabolic enzymes.  We 
focused on a subset of these genes and found that most are also Rhox5-regulated in the testes 
in vivo.  We determined the testicular cell types and developmental stages in which the 
regulation of each gene occurs.  We also identified other Rhox family members that regulate 
their expression, and provided evidence that the Rhox-dependent regulatory circuitry 
controlling these genes is conserved.  Finally, we addressed whether any of the Rhox5 gene 
targets are secondary androgen-response (SAR) genes.  These are long sought-after genes 
that are not directly regulated by androgen and AR, but rather are controlled by androgen-
dependent regulators, such as androgen-induced transcription factors (38, 39).  Because 
Rhox5 is an AR- and androgen-inducible gene in Sertoli cells, it is a good candidate to 
regulate SAR genes.  Indeed, we obtained many lines of evidence that several Rhox5-
regulated genes are SAR genes.  We also showed that other androgen-inducible Rhox genes 
(besides Rhox5) are capable of regulating these candidate SAR genes.  The discovery of 
genes coregulated by AR and RHOX transcription factors has the potential to begin illuminate 
the molecular mechanisms by which androgens drive spermatogenesis.  
 
Results  
Establishment of Sertoli cell clones expressing physiological levels of Rhox5  
To identify Rhox5 target genes by a gain-of-function approach, we screened Sertoli cell lines 
for those that express low endogenous Rhox5 mRNA levels.  Our rationale was that a low 
Rhox5-expressing line would provide an optimal baseline for identifying genes regulated by 
physiological levels of Rhox5 expressed from a Rhox5-expression vector.  We predicted that 
most Sertoli cell lines would express low levels of Rhox5, as we previously found that 
primary mouse Sertoli cells dramatically downregulate Rhox5 mRNA expression after only 1 
day in culture (30).  Indeed, we found that all three Sertoli cell lines that we tested—15P-1, 
MSC-1, and Tm4—expressed very low levels of Rhox5 mRNA, as judged by quantitative (Q) 
polymerase chain reaction (PCR) analysis (Supplemental Fig. S1).  The two cell lines with 
the lowest expression, 15P-1 and Tm4, expressed ~300-fold less Rhox5 mRNA than adult 
testes.  This is a conservative estimate of the difference given that Rhox5 mRNA is only 
expressed in Sertoli cells in the adult testis (26, 29).  Indeed, RHOX5 protein was 
undetectable in 15P-1 cells, as judged by Western blot analysis (Supplemental Fig. S2).  We 
chose 15P-1 over Tm4 for our gain-of-function study because we found that 15P-1 cells could 
be transfected more efficiently than Tm4 cells (using Lipofectamin; data not shown).  We 
also chose the 15P-1 cell line because it exhibits many normal Sertoli cell characteristics, 
including the expression of genes normally expressed by Sertoli cells (e.g., WT1 and Steel) 
and the ability to support the transit of male germ cells through meiosis (35, 40, 41).  
 To express Rhox5 in 15P-1 cells, a murine Rhox5 full-length cDNA was cloned into an 
expression vector under the control of the CMV immediate early promoter.  This construct 
was then stably transfected into 15P-1 Sertoli cells and several independent G418-resistant 
subclones were obtained.  Northern blot analysis demonstrated that many of the cell clones 
expressed Rhox5 mRNA at levels comparable to that in postnatal and adult testes (data not 
shown).  To confirm that Rhox5 was expressed, we employed Western blot analysis.  This 
showed that the stably transfected cell clones also expressed RHOX5 protein (Fig. 1A).  To 
obtain a quantitative assessment of Rhox5 mRNA levels, qPCR analysis was employed (Fig. 
1B).  This demonstrated that clones 6 and 24 expressed the highest level of Rhox5 mRNA 
and thus these 2 clones were chosen as the “Rhox5-positive” clones for microarray analysis.  
Clones 14 and 16, which had the lowest level of Rhox5 mRNA (comparable to the level in 
parental 15P-1 cells; data not shown), were chosen as the “Rhox5-negative” clones for 
microarray analysis.   
    
Identification of genes regulated by Rhox5 in Sertoli cells 
Total cellular RNA was isolated from clones 6, 24, 14 and 16 and analyzed by microarray 
analysis.  The digitally captured data was analyzed using GeneSpring software to determine 
the genes that were differentially expressed between the four samples in all pairwise 
combinations.  This analysis revealed that 182 genes were either upregulated or 
downregulated by 2-fold or more in the Rhox5-positive cell clones as compared to the Rhox5-
negative cell clones (Supplemental Tables 1 and 2).  The Rhox5-regulated genes that we 
identified by this approach encode proteins encompassing a broad range of functions.  We 
used OntoExpress software to classify them and put them into categories based on gene 
ontology classification (42).  Supplemental Figure 3 provides a graphical representation of 
the molecular function analysis, biological process analysis, and cellular component analysis 
for the proteins encoded by all 182 genes.  Supplemental Figs. 4 and 5 provide the same type 
of information for only the Rhox5-upregulated and -downregulated genes, respectively.  
Compared to the whole mouse genome, the Rhox5-regulated genes were not statistically 
overrepresented in any one category but rather were involved in a wide array of molecular 
and cellular functions.   
 
In vitro regulation and cellular site of expression in vivo  
To verify the regulation observed by microarray analysis, we performed qPCR analysis on 15 
of the 182 genes (Table 1).  Nine of them encode membrane-bound proteins, which we 
chose because such proteins could mediate Rhox5-dependent signaling between Sertoli cells 
and germ cells.  The other 6 genes were selected for various reasons. Carboxypeptidase X1 
(Cpxm1) and ganglioside-induced differentiation associated protein 1 (Gdap1) were chosen 
because they are dramatically regulated by Rhox5, according to our microarray analysis 
(Table 1).  BTB and CNC Homology 2 (Bach2) and kruppel-like factor 9 (Klf9) encode 
transcription factors with well-established functions; the latter is known to have a role in 
female reproduction and neuronal development (43, 44).  Lastly, isocitrate dehydrogenase 3 
(Idh3a) and 2,3-bisphosphoglycerate mutase (Bpgm) were selected because they encode 
proteins directly involved in metabolism.  This was of interest because we have found that 
Rhox5 regulates many other genes involved in metabolism (determined using an independent 
approach to the one we took here; MacLean J, Hu Z, and Wilkinson MF, unpublished 
observations).   
To verify the regulation of these 15 genes, qPCR was performed on total cellular RNA 
from the four original 15P-1 clones used for microarray hybridization (6, 24, 14, and 16), as 
well as other 15P-1 stable clones expressing different levels of Rhox5 mRNA (clones 1, 4, 11, 
19, and 26; data not shown).  This analysis demonstrated that all 15 of the transcripts that we 
tested were regulated in precisely the same manner as indicated by microarray analysis (Table 
1).  Furthermore, the magnitude of the regulation for most of the transcripts was similar 
when measured by either qPCR analysis or microarray analysis.  
To assess which of these 15 genes are candidates to be direct targets of Rhox5, we 
assessed whether they are expressed in Sertoli cells, the site of Rhox5 expression (29).  To 
do this, we generated an enriched Sertoli cell fraction from adult testes using a modified 
protocol involving gravity sedimentation and enzymatic treatments (see Materials and 
Methods).  This procedure also generates purified interstitial (mainly Leydig) cells, which 
allowed us to determine whether any of these Rhox5-regulated genes are also expressed in 
this somatic cell subset.  Hypotonic shock was used to lyse most of the contaminating germ 
cells in both Sertoli- and interstitial-enriched fractions (45).  By comparing gene expression 
in Sertoli- and interstitial cell fractions prepared with or without hypotonic shock, we were 
able to assess the contribution of germ cells.  Although it is not possible to generate entirely 
pure populations of these cell types, our protocol yielded fractions that were substantially 
enriched, based on their relative expression of Sertoli (Gata1 and Rhox5) (29-31, 46) and 
Leydig cell markers (luteinizing hormone (LH) receptor [Lhr]) (47).  To assess the 
effectiveness of hypotonic shock in removing germ cells, we assessed the levels of two germ 
cell-specific genes: testicular orphan receptor-2 (Tr2) and Deleted in Azoospermia-like (Dazl) 
(48, 49).  
Table 2 shows the expression of the 15 Rhox5-regulated genes in the different cell 
subsets, as assessed by qPCR analysis.  Five of the genes were predominantly expressed in 
Sertoli cells (group 1), based on two criteria.  First, they were more highly expressed in the 
Sertoli cell fraction that underwent hypotonic shock and than the one that did not (under the 
headings “Sertoli cells” and “Sertoli no-shock,” respectively).  Second, they were more 
highly expressed in the purified Sertoli cell fraction than in total testes (the latter of which 
was given a value of “1”).  Of note, however, we found that the magnitude of the increased 
expression in the purified Sertoli cell fraction (relative to total testes) varied considerably 
between genes.  This may, in part, be the result of some of the genes being expressed in 
other cell types in the testes.  Another possible contributing factor is that our procedure may 
not equally purify Sertoli cells in all stages of the seminiferous epithelial cycle.  This would 
lead to different levels of enrichment, depending on the pattern of expression of a given gene 
during the seminiferous epithelial cycle.  For example, the positive control, Gata1, has been 
shown to be expressed exclusively by Sertoli cells but because it exhibits stage-specific 
expression (50), this could explain why we found its expression was increased by less in the 
purified Sertoli cell fraction (~4-fold) than one of the Rhox5-regulated genes, interferon 
receptor-2 (Ifnar2), which exhibited ~8-fold increased expression.  As another example, the 
Rhox5-regulated genes, Tfc, which encodes the transferrin receptor, was previously shown to 
be specifically expressed only by Sertoli cells in the testes (51), but we found it was only 
expressed at ~2-fold higher levels in the purified Sertoli cell fraction than in total testes.  We 
suggest that this may be explained by its stage-specific expression (52).  We did find that Tfc 
expression was relatively Sertoli cell-specific, as Tfc mRNA was at ~10-fold higher levels in 
the purified Sertoli cell fraction than in the purified Leydig cell fraction.  
We divided the other 9 Rhox5-regulated genes into 3 categories: (i) those expressed in 
both the Sertoli- and interstitial-cell fractions (group 2), (ii) those expressed predominantly in 
the interstitial-cell fraction (group 3), and (iii) those predominantly expressed in testicular cell 
types other than Sertoli cells or interstitial cells (group 4).  The group-2 genes are candidates 
to be directly regulated by Rhox5, while those in groups 3 and 4 probably are indirectly 
regulated through paracrine signaling from Sertoli cells.  We note, however, that Bpgm, 
which is in group 4 because it was less expressed in the Sertoli and interstitial fractions than 
in total testes, exhibited significantly increased expression in purified Sertoli cells than in 
non-shocked Sertoli cells, which suggests that it is expressed in at least a subset of Sertoli 
cells.  Together, these results provide evidence that ~60% of the Rhox5-regulated genes that 
we selected for in-depth analysis are expressed in Sertoli cells in the adult testes in vivo. 
 
In vivo regulation 
While the 15P-1 cell line has many Sertoli cell characteristics (35, 37), it is an immortalized 
cell line adapted to tissue culture and thus it does not completely mimic normal Sertoli cells.  
Hence, it was crucial to determine whether the genes regulated by Rhox5 in 15P-1 cells were 
also regulated by Rhox5 in vivo.  We took 3 approaches to address this question.  First, we 
compared their expression in adult testes from Rhox5-null and control mice.  Second, we 
compared their expression in purified somatic cell fractions from Rhox5-null and control adult 
testes.  Third, we compared their postnatal pattern of expression in Rhox5-null and control 
mice.  The first approach revealed that 5 of the 15 genes were significantly regulated by 
Rhox5 in the adult testis: cluster-w4 antigen (Cd24a), transmembrane protein (Tmem) 176a, 
Tmem176b, Klf9, and Cpxm1 (Fig. 2).  All 5 of these genes were upregulated in the Rhox5-
null adult testes, indicating that they are negatively regulated by Rhox5 in vivo.  Consistent 
with this, 4 of these genes were repressed by Rhox5 in 15P-1 cells (Table 1).  The lone 
exception, Cd24a, was strongly upregulated by Rhox5 in 15P-1 cells, whereas it was modestly 
downregulated by Rhox5 in the adult testes.  Three of the genes—Tmem176a, Tmem176b, 
and Klf9—were downregulated by similar magnitudes in 15P-1 cells and the adult testis.  
Because molecular analysis of the whole testes will often not reveal genes regulated by 
Rhox5 in only a specific subset of testicular cells, we also examined Rhox5-mediated 
regulation in adult testicular cell subsets.  Because we found that most of the Rhox5-
regulated genes are expressed in the enriched Sertoli cell and interstitial cell fractions, we 
examined these two cell subsets.  Figure 3 shows the ratio of gene expression in these two 
fractions prepared from Rhox5-null and control mice (note that the ratio is the average of two 
independent experiments and is presented on a log scale).  The data indicate that several 
genes are regulated by Rhox5 in the Sertoli cell fraction, the interstitial cell fraction, or both.  
Of the 5 genes up- or down-regulated by 2-fold or more in Sertoli cells (indicated with an “a” 
in Fig. 3, upper panel), 4 were regulated in the same manner in response to Rhox5 in 15P-1 
cells (Table 1).  The lone exception, Frizzled homolog 2 (Fzd2), was upregulated by Rhox5 
in the Sertoli cell fraction in vivo and modestly downregulated by Rhox5 in 15P-1 cells. 
However, Fzd2 expression was downregulated by Rhox5 in the interstitial fraction, indicating 
that it is regulated in the same manner by Rhox5 in interstitial cells in vivo as it is the 15P-1 
cell line.  Three of the other 4 genes regulated by 2-fold or more in the interstitial cell 
fraction (indicated with an “a” in Fig. 3, lower panel) were also regulated in the same manner 
in vitro (Table 1).  Together, this data indicated that 4 additional genes (beyond those 
identified in total adult testes) are Rhox5 regulated in vivo: Fzd2, Gdap1, Pltp, and Tmem47 
(also known as Tm4sf10).  All 4 of these genes are expressed in purified Sertoli cells (Table 
2) and regulated by Rhox5 in Sertoli cells (Fig. 3), indicating that they are all candidates to be 
direct targets of RHOX5.  
As a final approach to assess the regulation of these 15 genes by Rhox5 in vivo, we 
examined their expression pattern during the first wave of spermatogenesis in Rhox5-null and 
control mice.  This approach provided an independent assessment of Rhox5-mediated 
regulation and it had the potential to pinpoint the stage(s) of spermatogenesis at which Rhox5 
acts on its target genes.  This analysis demonstrated that 5 of the 15 genes were significantly 
regulated by Rhox5 at one or more time points during the first wave of spermatogenesis (Fig. 
4 and Supplemental Fig. S6).  While some of these genes were regulated by Rhox5 only 
transiently during the first wave of spermatogenesis (i.e., at very specific postnatal time 
points), the regulation was reproducible.  Furthermore, all 5 of these genes exhibited the 
same regulation in vitro.  Thus, 3 of the genes (Fzd2, Unc5c, and Tmem176a) were 
downregulated by Rhox5 both in vivo and in 15P-1 cells, whereas the other 2 genes (Cd24a 
and Gdap1) were upregulated by Rhox5 both in vivo and in 15P-1 cells (Fig. 4 and Table 1).  
Three of the genes (Fzd2, Gdap1, and Tmem176a) were also regulated in adult testes in the 
same manner as they were in postnatal testes (Figs. 2 and 3).  Four of the genes were 
expressed and/or regulated in purified Sertoli cells (Table 2 and Fig. 3), indicating that they 
are candidates to be direct targets of Rhox5.   
Together, the data derived from these 3 different approaches indicated that 10 of the 15 
genes regulated by Rhox5 in the 15P-1 Sertoli cell line are also regulated by Rhox5 in the 
testis in vivo.  Seven of these 10 are expressed in the enriched Sertoli cell fraction and thus 
may be directly regulated by Rhox5 (Table 2).  
 Rhox5 targets Ar-regulated genes  
The Rhox5 gene depends on the nuclear hormone receptor AR and androgen for expression in 
Sertoli cells (see Introduction and Discussion).  This led us to hypothesize that a subset of 
Rhox5-regulated genes are also regulated by AR and androgen.  In other words, we 
hypothesized that a subset of Rhox5-regulated genes are secondary androgen-responsive 
(SAR) genes that are androgen regulated through the action of Rhox5.  As a first test of this 
hypothesis, we determined whether any of the 15 Rhox5-regulated genes described above are 
regulated by AR in vivo.  To do this, we examined their expression in Sertoli cell AR-
knockout (Scarko) mice, which have Ar mutated conditionally in Sertoli cells (53), and 
testicular feminized (Tfm) mice, which have a naturally occurring mutation in the Ar gene that 
inactivates AR function (54).  qPCR analysis of adult testes from these mutant mice revealed 
that 11 of the 15 Rhox5-regulated genes had significantly altered expression compared to 
control testes (Fig. 5).  Eight of these genes were regulated in the same manner by Ar and 
Rhox5 (either positively or negatively in response to both), indicating that these are candidate 
SAR genes.  Six of them had significantly altered expression in both Scarko and Tfm mice, 
providing strong evidence that these genes are bona fide AR-regulated genes.  The other two 
genes, Fzd2 and Pltp, were only regulated in Scarko mice, not Tfm mice.  While there are 
many possible explanations for this, a likely one is that because Tfm mice are cryptorchid (55); 
the abnormally high temperature of the testes in these mice prevents normal AR-mediated 
regulation of these two genes.  
The signature feature of SAR genes is that they do not directly respond to AR (39, 56).  
To determine if the 8 candidate SAR genes have the potential to respond to AR, we examined 
their 5′and 3′flanking regions for androgen-response elements (AREs) using the 
Gemomatix program.  Four of these genes had no consensus AREs, while the other 4 had 
either 1 or 2 consensus AREs (Supplementary table 3).  To empirically determine whether 
the 8 candidate SAR genes do not directly respond to AR, we examined whether their 
expression was altered in response to AR and androgen under conditions when Rhox5 is not 
induced.  This was accomplished using 15P-1 cells, which does not exhibit increased Rhox5 
mRNA levels in response to the testosterone analog R1881 and transfection with an AR 
expression plasmid (Supplementary Fig. S6).  We found that AR and R1881 did not 
significantly affect the expression of any of the 8 candidate SAR genes in the 15P-1 cell line 
(Supplemental Fig. S7).  In contrast, AR and R1881 did increase the expression of the AR-
regulated gene Fabp (data not shown).  
As another test of AR/androgen responsiveness, we generated a luciferase reporter 
construct containing 3 kb of 5′flanking sequence from the candidate SAR gene Unc5c (Fig. 
6A).  We chose Unc5c because it harbors no consensus AREs in this region (Table 3 and 
data not shown).  When contransfected into the MSC1 Sertoli cell line with an AR 
expression plasmid and incubated with R1881, this Unc5c promoter construct did not exhibit 
altered luciferase expression (Fig. 6B).  In contrast, the positive control, a luciferase reporter 
construct containing the Rhox5 proximal promoter (Pp) (Fig. 6A), expressed greatly elevated 
levels of luciferase in response to AR and R1881 (Fig. 6B).  Note that while the Rhox5 Pp 
reporter was greatly increased in expression in response to AR and R1881, the endogenous 
Rhox5 gene was not significantly elevated in expression (as judged by qPCR analysis; data 
not shown), probably because it is in a repressed state due to DNA methylation (17, 57).  
The ability of Unc5c to respond to AR only under conditions in which Rhox5 expression is 
also induced (Figs. 5 and 6), coupled with the ability of Unc5c to be regulated by Rhox5 both 
in vitro and in vivo (Table 1 and Fig. 4, respectively), provides strong evidence that Unc5c is 
regulated by AR through the action of Rhox5.  
 
Identification of common targets of AR-regulated Rhox genes   
In the previous section, we provided evidence that we had identified SAR genes that are 
regulated by AR through the action of the AR-inducible gene Rhox5.  As another means to 
address whether we identified bona fide SAR genes, we determined whether they are 
regulated by other AR-inducible Rhox genes.  We previously demonstrated that Rhox2, 
Rhox3, Rhox10, and Rhox11 are all strongly upregulated in expression in response to AR and 
androgen in Sertoli cells (7).  Thus, we examined whether any of these other AR-inducible 
Rhox genes were capable of regulating the putative SAR genes we had identified.  The 
putative SAR genes that we selected for this analysis were those that fulfilled 3 criteria: (i) 
regulated by Rhox5 in vivo, as judged by our 3-prong analysis (Figs. 2-4), (ii) regulated by 
AR in vivo (Fig. 5), and (iii) significantly expressed in the purified Sertoli cell fraction (Table 
2, category 1 or 2).  The 6 genes that fulfilled these criteria were Gdap1, Tmem176a, 
Tmem176b, Fzd2, Pltp, and Unc5c.  To determine whether these 6 genes are regulated by 
AR-regulated Rhox genes, we transiently transfected expression vectors encoding RHOX2, 
RHOX3, RHOX5, RHOX10, and RHOX11 into 15P-1 cells (we previously showed that all 
these RHOX proteins are all expressed at similar levels from these expression vectors (32).  
qPCR analysis revealed that each of the 6 SAR genes was significantly regulated in response 
to at least 2 of the AR-inducible Rhox genes (Fig. 7A).  For example, Unc5c was negatively 
regulated by Rhox3, Rhox5, and Rhox10.  Tmem176a and Tmem176b were also regulated by 
Rhox3 and Rhox5, but instead of being regulated by Rhox10, these two genes responded to 
Rhox11.  Pltp had the same pattern of expression as Tmem176a and Tmem176b, except that 
Rhox2 also negatively regulated its expression.  Fzd2 had an unusual pattern of expression in 
that it was negatively regulated by Rhox2, Rhox3, Rhox5, and Rhox11, but was positively 
regulated by Rhox10.  To assess specificity, we also evaluated the effect of Rhox8, which is 
not AR regulated, either as assessed in a Sertoli cell line (7) or in postnatal and adult testes in 
vivo (MacLean J., de Gendt K, Verhoeven G., and Wilkinson M.F., unpublished observations).  
We found that forced expression of Rhox8 did not significantly affect the expression of any of 
the SAR genes except for Gdap1.  Rhox8 positively regulated Gdap1, as did Rhox5 and 
Rhox10.  Of note is that we found that transiently transfected Rhox5 only modestly regulated 
the SAR genes (Fig. 7A), which contrasted with its more dramatic effects on some of the 
SAR genes in cells stably transfected with Rhox5 (Table 1; i.e., Gdap1, Pltp, and Unc5c).  
Regardless of this quantitative difference, Rhox5 had the same qualitative effect on the 6 SAR 
genes in transiently and stably transfected cells (i.e., Rhox5 negatively regulated all the SAR 
genes except for Gdap1 under both conditions).   
To determine whether the regulation of the putative SAR genes is a conserved response, 
we examined the effect of forced expression of human RHOXF1 and RHOXF2.  These are 
the only human RHOX genes that have been characterized; both are selectively expressed in 
human testes (58, 59).  RHOXF1 is an androgen-induced gene, while RHOXF2 has not been 
characterized in this regard (58).  We found that transient transfection of expression vectors 
encoding either RHOXF1 or RHOXF2 triggered the downregulation of Unc5c and Pltp (Fig. 
7B).  RHOXF2, but not RHOXF1, upregulated Gdap1 expression, while RHOXF1, but not 
RHOXF2, modestly decreased the expression of both Tmem176 and Tmem176b.  The only 
putative SAR gene that did not significantly respond to either RHOXF1 or RHOXF2 was 
Fzd2.  We conclude that human RHOXF1 and RHOXF2 share with androgen-regulated 
mouse Rhox family members the ability to regulate most of the SAR genes, suggesting that 
this is a conserved response.  
 
Discussion  
Homeobox genes were originally identified over 25 years ago and have since been shown to 
control a wide variety of developmental and cellular events from yeast to mammals, yet 
surprisingly little is known about the gene networks downstream of homeobox genes.  The 
discovery of the Rhox homeobox gene cluster provides an opportunity to identify gene 
networks important for male and female gametogenesis.  In this report, we focused on 
identifying genes downstream of Rhox5, the founding member of the Rhox gene cluster.  
This Sertoli cell-expressed gene promotes the survival of mouse male germ cells in all stages 
of the seminiferous epithelial cycle (7).  Rhox5 is also required to generate normal levels of 
motile spermatozoa and for normal male fertility (7).  To identify physiologically relevant 
genes downstream of Rhox5 that might mediate these functions, we took a two-prong 
approach in which we first identified Rhox5-regulated genes using genome-wide expression 
profiling in a Sertoli cell line and then followed that up with in vivo analysis.  We favored 
using a Sertoli cell line for our initial screen of Rhox5-regulated genes for several reasons.  
First, this allowed us to identify regulated genes in a relatively homogenous set of cells.  By 
contrast, analysis of whole testes and testicular cell subsets has potential problems with 
cellular heterogeneity and cellular contamination, respectively.  Second, the Sertoli cell line 
we chose for our analysis, 15P-1, expresses little or no Rhox5 mRNA or RHOX5 protein 
(Supplementary figs. 1 and 2, respectively), which allowed us to take a simple gain-of-
function approach to identify Rhox5-regulated genes.  Third, we carefully selected stably 
transfected 15P-1 cell clones that expressed normal levels of Rhox5 to allow us to screen for 
physiologically relevant Rhox5-regulated genes.  Finally, 15P-1 is an ideal cell line to 
perform molecular studies on the molecular mechanisms by which RHOX5 regulates its 
target genes, as these cells are transiently transfected efficiently and they exhibit many normal 
Sertoli cell characteristics, including many Sertoli cell markers and the ability to support the 
differentiation of germ cells (35-37, 40, 41).    
 Using this approach, we identified many genes regulated by Rhox5 (Table 1), 
including those encoding proteins involved in a wide variety of functions (Supplementary 
table 1 and 2).  We focused on 15 of these genes by first verifying that they are regulated by 
Rhox5 in 15P-1 cells (Table 1) and then conducting an in-depth analysis of their expression 
pattern and regulation in response to Rhox5 in vivo (Figs. 2-4).  By analyzing (i) adult testes, 
(ii) purified cell fractions from adult testes, and (iii) postnatal testes from many time points 
during the first wave of spermatogenesis from both Rhox5-null and control littermate mice, 
we found that at least 11 of these 15 genes are regulated by Rhox5 in vivo (Table 1, Figs. 2-4). 
Seven of these 11 in vivo Rhox5-regulated genes are expressed in Sertoli cells, based on our 
cell-subset fractionation analysis (Table 2), and thus are candidates to be directly regulated by 
Rhox5.  Direct analysis of whether they are direct targets is complicated by the need for a 
ChIP-grade RHOX5 antisera and the fact that the cis elements responsible for regulation 
could be far from their promoter regions.  We showed that many of these Sertoli cell-
expressed genes are androgen- and/or AR-regulated (Fig. 5) and thus they may mediate some 
of the actions of androgen in the testes, as discussed in more detail below.  Interestingly, 6 of 
these 7 genes encode cell-surface proteins and thus they may be involved in cell-cell signaling 
between Sertoli cells and/or between Sertoli and developing germ cells.  
While some Rhox5-regulated genes appeared to be expressed and regulated exclusively 
in Sertoli cells, many Rhox5-regulated genes were expressed and/or regulated in other 
testicular cell types.  For example, we found that a number of the Rhox5-regulated genes 
were expressed in both the Sertoli and interstitial cell fractions (Table 2, category 2); some of 
these were regulated by Rhox5 in the interstitial cell fraction (Fig. 3).  We also identified a 
gene exclusively expressed in the interstitial cell fraction—Cd24a (Table 2, category 3)—that 
exhibited modestly altered expression in Rhox5–null mice (Figs. 3 and 4), suggesting that 
Cd24a is regulated by Rhox5 in a paracrine manner.  Other Rhox5-regulated genes were 
expressed at very low levels in both the Sertoli and interstitial cell fractions (Table 2, category 
4) and thus these genes may be regulated by Rhox5 in other testicular cell types, such as germ 
cells or myoid cells.  The overall picture that emerges from this analysis of 15 Rhox5-
regulated genes is that even though RHOX5 protein is restricted to Sertoli cells (30, 31), its 
web of regulation extends to various cell types in the testes. 
Because Rhox5 is an androgen- and AR-induced homeobox gene (29-31), it is a 
candidate to encode a transcription factor that mediates some of the actions of androgen in the 
testes.  This predicts that a subset of RHOX5 targets are SAR genes; i.e., genes indirectly 
regulated by AR through the action of intermediate factors (60).  While several SAR genes 
have been defined in the prostate (39, 61), to our knowledge none have been defined in the 
testes.  It is crucial to define SAR genes in the testis, as such genes are likely to be mediators 
of androgen action in this male reproductive organ.  Progress on this front has been stymied 
by the fact that very few androgen-regulated transcription factors have been identified in the 
Sertoli cell, the only cell type definitively known to mediate androgen action in the testes (6).  
To our knowledge, the only androgen-induced transcription factor genes that have been 
defined in Sertoli cells are Rhox5 and c-myc.  Rhox5 is androgen- and AR-induced in both 
cultured Sertoli cells and Sertoli cells in vivo (29-31, 46, 53, 62-64),  while c-myc is 
androgen inducible in cultured Sertoli cells (65) but it appears not to be AR regulated in vivo 
(53, 55).  In this paper, we provide several lines of evidence that we have identified 8 SAR 
genes that are regulated by AR through the action of Rhox5 in the testes.  First, all 8 of these 
genes are regulated by Rhox5 in 15P-1 Sertoli cells (Table 1) and all but one of them (Ifnar2) 
are regulated by Rhox5 in the testes in vivo (Figs. 2-4).  Second, our analysis of Ar-deficient 
mice indicated that all 8 of these genes are AR regulated in adult testes in vivo (Fig. 5).  As 
confirmation of this, we found that 5 of these genes (Bpgm, Cpxm1, Ifnar2, Tmem176a, and 
Tmem176b) were independently defined as “AR regulated” by a study that used microarray 
analysis to identify genes differentially expressed in postnatal Tfm Ar-deficient and control 
mice testes (55).  Third, our analysis of the putative regulatory regions in the candidate SAR 
genes showed that 4 of them had no consensus AREs and the other 4 had few consensus 
AREs (Table 3).  Because, by definition, SAR genes are regulated indirectly by AR, this 
paucity of AREs is consistent with these genes being bona fide SAR genes.  We should note, 
however, that AREs are notoriously difficult to define, as consensus sites are often not 
functional and it is common for functional sites to differ considerably from the consensus 
sequence (66).  Fourth, none of the 8 genes were regulated by AR and androgen under 
conditions in which Rhox5 was not induced (Supplementary Fig. 7).  Fifth, a reporter 
construct harboring the promoter region of one of the candidate SAR genes (Unc5c) was 
responsive to Rhox5, but was not responsive to AR and androgen under conditions in which 
Rhox5 was not induced (Fig. 6).  Sixth, several androgen/AR-inducible mouse Rhox genes 
besides Rhox5 regulated many of the candidate SAR genes (Fig. 7A).  Finally, RHOXF1, an 
androgen-inducible human RHOX gene (58), was also capable of regulating some of the 
candidate SAR genes (Fig. 7B), providing evidence that this is a conserved response.  
Interestingly, human RHOXF2 also regulated many of these genes (Fig. 7B), but whether it is 
an androgen-inducible gene has not yet been determined.  
Consistent with the often noted connection between the testis and the brain (67), we 
found that a remarkably large proportion of the candidate SAR genes encode proteins with 
known functions in the nervous system.  Unc5c encodes a transmembrane receptor of the 
immunoglobulin superfamily that binds to netrin-1, a protein important for many 
developmental events in the brain, including governing axon migration by triggering 
chemorepulsion (68).  UN5C also has a “death domain,” which engenders it with 
proapoptotic activity that may also be important for its roles in brain development (69).  We 
recently showed that UNC5C functions similarly in the testes by promoting the death of male 
germ cells (32).  This germ cell death-promoting property, coupled with the fact that Unc5c 
gene expression is negatively regulated by Rhox5, makes Unc5c a good candidate to have a 
role in Rhox5’s ability to promote the survival of germ cells (7).  Another candidate SAR 
gene, Gdap1, is upregulated during neuron differentiation (70) and, when mutated in humans, 
is responsible for many cases of Charcot-Marie-Tooth disease, the most common inherited 
form of peripheral neuropathy.  GDAP1 is a member of the glutathione-S transferase family 
and thus its neurologic protective role may derive from its antioxidant properties.  
Tmem176b (also known as Clast1, Lr8, and TORID) encodes a ubiquitously expressed 4-
transmembrane cell-surface protein that is crucial for normal brain development and function.  
Targeted deletion of Tmem176b in mice causes defects in the cerebellum and severe ataxia 
(71).  It has not been reported whether Tmem176b-mutant mice have defects in male fertility, 
but our finding that both Ar and Rhox5 regulate its expression suggests it may have some role 
in androgen-mediated events in the testes.  A related 4-transmembrane protein-encoding 
gene, Tmem176a (also known as GS188 and HCA112), is another putative SAR gene.  At 
present, there is no information on either the biochemical or biological function of Tmem176a.  
Another candidate SAR gene, Pltp, encodes a protein that acts both inside and outside of cells 
to mediate the transfer of lipids.  While PLTP is fairly widely expressed and therefore 
probably acts in many cell types, it appears to be particularly important for brain function, in 
part, by virtue of its being secreted by neurons and glial cells.  PLTP is likely to have roles 
in neurodegenerative and inflammatory brain diseases, including Alzheimer’s disease, as 
PLTP levels are altered in many of these disease states.  PLTP also alters the 
phosphorylation state of TAU, a neuron-specific protein that undergoes shifts in 
phosphorylation status in many neurological diseases (72).   
The remaining three candidate SAR genes, Fzd2, Ifnr2, and Bpgm, are likely to have 
roles in many cell types.  Fzd2, encodes 1 of the 10 known frizzled receptors in mice; these 
are cell-surface receptors that bind to the WNT family of secreted glycoproteins.  Upon 
binding of WNT proteins, Frizzled receptors elicit signal transduction events crucial for 
conserved developmental steps in many organisms.  Because frizzled receptors tend to act 
redundantly, it has been difficult to assign precise functions to them, including FZD2 (73).  
Ifnar2 encodes the cell surface receptor for anti-viral cytokines called interferons.  Upon 
interferon binding, IFNAR2 activates the STAT signaling pathway, which in turn elicits an 
anti-viral response, including rapid mRNA decay and translational repression (74).  Bpgm 
encodes a multifunctional enzyme best known for its role in controlling the metabolism of 
2,3-diphosphoglycerate in erythrocytes (75).  It will be interesting to know what specific 
roles BPGM has in the testes.  
In addition to the candidate SAR genes described above, we identified 4 other genes 
regulated by Rhox5 in the testes in vivo: Cd24a, Klf9, Cpxm1, and Tmem47 (Figs. 2-4).  Two 
of these, Cd24a and Klf9, also have known roles in the nervous system.  Cd24a encodes a 
glycosylphophatidylinositol-anchored glycoprotein that was originally identified on the basis 
of its expression in immune cells but was subsequently shown to also be expressed and have a 
role in neurons.  In the adult mouse central nervous system, CD24 expression is restricted to 
immature proliferating neurons in regions of the brain undergoing neurogenesis.  CD24 
serves to dampen the proliferation of these neurons, as Cd24a-knockout mice exhibit 
increased numbers of proliferating neurons in these zones (76).  Kfl9 (also known as Bteb1) 
encodes a zinc-finger transcription factor that when knocked out in mice leads to cerebellar 
Purkinje cell defects and behavioral defects consistent with its having roles in the cerebellum, 
amygdala, and hippocampus (77).  While exactly how KLF9 functions in the brain is not 
known, in vitro experiments have suggested it has a role in neurite extension and branching in 
vitro (44).  Tmem47 encodes a 4-transmembrane protein that is a member of a different 
subfamily than Tmem176a and Tmem176b, the other 4-transmembrane protein genes 
regulated by Rhox5.  The functional role of TMEM47 in mammals is not known, but its 
ortholog in C. elegans, VAB-9, is crucial for the formation of adherens junctions in epithelial 
cells (78).  Thus, it is tempting to speculate that TMEM47 might function in the formation 
and/or maintenance of the testes-specific adherens junctions that form between Sertoli cells 
and germ cells: the ectoplasmic specialization.    
Future studies will be required to precisely define the gene networks downstream of AR 
and the AR-regulated Rhox genes and to identify their roles in spermatogenesis.  One 
essential question will be to delineate which functions of AR require the action of androgen-
regulated Rhox genes.  Studies in AR-deficient mice harboring either a non-functional Ar 
allele in Sertoli cells or a hypomorphic Ar allele in all cells have revealed that AR has at least 
3 functions: (i) it promotes the progression of meiotic spermatocytes, (ii) it promotes the 
maturation and/or survival of round spermatids, allowing the generation of elongating 
spermatids, and (iii) it promotes the final maturation and release of elongated spermatids into 
the lumen of the seminiferous tubules (62, 64, 79, 80).  Thus, androgen-inducible Rhox 
genes may be involved in any or all of these events.  Another question for the future will be 
to determine which Rhox5-regulated genes in Sertoli cells are direct targets of RHOX5.  This 
will be a challenge to answer, as a RHOX5-binding consensus sequence has yet to be defined 
and RHOX5 may act on enhancers far upstream or downstream of its target genes.  Finally, 
it will be intriguing to understand how Rhox5 regulates genes in cell types in addition to the 
Sertoli cell, the only cell type that significantly expresses Rhox5 (26, 29).  Given that a large 
proportion of Rhox5-regulated genes encode cell-surface and secreted proteins (Supplemental 
Fig. S3), an obvious mechanism by which it could act is to influence cell-cell interactions and 
signaling events occurring between Sertoli cells and other cell types in the testis.  By 
defining and characterizing Rhox-regulated genes in vitro and in vivo, we believe that the 
work presented in this paper provides a foundation to address these many future issues. 
 
 
Materials and Methods  
 Cell Culture and Transfection  
The 15P-1 and MSC1 cell lines were maintained in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum and 50 mg/ml of both penicillin and streptomycin.  
The cells were grown at 37oC in 5% CO2 atmosphere and split when ~80% confluent.   
 
To generate stable Rhox5 expression plasmid transfected clones, 15P-1 cells cultured to ~60% 
confluency in 100 mm plates were transfected with 2 µg of Rhox5 expression plasmid using 
lipofectamine (Invitrogen, Carlsbad, CA) and clones resistant to antibiotic (700 µg/ml G418) 
were selected. 
  
The concentration of plasmids used for transfection was independently determined using both 
a fluorometer and analytical gel electrophoresis.  For transient transfection analysis, 15P-1 
cells were plated in 60mm dishes the day before transfection at a density of ~2×106 cells per 
dishes in 4 ml of growing medium.  On the day of transfection, 800 ng of plasmid DNA was 
diluted with 150 µl of serum-free medium and mixed with 150 µl of serum-free media 
containing 3 µl Lipofectamine (Invitrogen, Carlsbad, CA), incubated at room temperature for 
30 min, and the DNA-lipid complex was added to the wells and incubated at 37 °C in a CO2 
incubator for 5 h.  Cells were harvested 36 h post-transfection for RNA analysis.  MSC1 
cells were transfected using Fugene 6 (Roche Diagnostics, GmbH, Mannheim, Germany) 
following the manufacturer’s instructions. Cells were plated on 12-well culture dishes and 
then cotransfected with 100 ng of the Rhox5/Unc5c-containing plasmids and 100 ng of either 
the AR expression plasmid or empty vector.  After a 6-h incubation in DMEM supplemented 
with 10% charcoal-stripped bovine serum (HyClone Laboratories, Inc., Logan, UT),  R1881 
was added at final concentration of 10 nM. Cells were harvested 36 h post-transfection for 
luciferase assay using the Dual Luciferase Assay System (Promega, Madison, WI), following 
the manufacturer’s instructions. The relative luciferase activity was calculated by normalizing 
against the co-transfected internal control pRL-null. The results shown are the mean ± SEM 
of three independent transfection experiments. 
 
Plasmids  
The Unc5c-P (G734) and Rhox5-Pp (Pem250) plasmids used in this study were generated 
previously (32, 46).  The Rhox expression plasmids used in this study were generated 
previously (32).  The human AR pcDNA 3.1 plasmid (G541) was kindly provided by 
Zhengxin Wang (The University of Texas M. D. Anderson Cancer Center, Houston, TX). 
 
RNA and protein analysis  
Total cellular RNA was prepared from cell lines and tissues as described previously by 
guanidinium isothiocynate lysis and centrifugation over a 5.7 M CsCl cushion (81). The 
Rhox5 cDNA probe used for Northern blot analysis was prepared as described previously (24).  
Real-time reverse transcriptase (RT) polymerase chain reaction (PCR) analysis was 
performed as described previously (7) using primers as described in Table 1. Microarray 
analysis with 15P-1 stable cell clones was performed at the University of Iowa DNA core 
facitlity on total cellular RNA from clones no.6, 24, 14, and 16 (refer to Fig. 1C), using an 
Affymetrix mouse genome GeneChip 430 2.0 array. This gene chip independently samples 
approximately 45,101 probe sets, which corresponds to approximately 39,000 genes.  
For western blot analysis, 20 µg of total cell lysates were electrophoresed in a 10% SDS–
polyacrylamide, transferred to Hybond ECL nitrocellulose (Amersham, Piscataway, NJ), and 
probed with antibody against RHOX5 or β-actin (Sigma, St. Louis, MO).  The membranes 
were given three 10-min washes with 0.1% Tween-20 in phosphate-buffered saline at room 
temperature and then incubated for 45 min at room temperature with the 2° antibody (ECL kit 
anti-rabbit or anti-mouse from Amersham, Piscataway, NJ) at a dilution of 1:5,000.  The 
filter was developed by using the ECL-Plus reagent according to manufacturer’s protocol 
(Amersham, Piscataway, NJ).   
 
Testis cell fractionation  
Sertoli and interstitial cells were purified from testes as previously described (7, 82).  In 
brief, testes were decapsulated and the seminiferous tubules were allowed to settle in 
phosphate-buffered saline, followed by incubation in collagenase (C2674; Sigma Inc.).  
Following another round of settling, the supernatant, which was enriched for interstitial cells, 
was subjected to hypotonic shock (by incubation in 1:7 diluted phosphate-buffered saline for 
3 min) to remove germ cells, and the surviving cells were pelleted and the RNA extracted.  
The pellet obtained after collagenase treatment, which was enriched for Sertoli cells, was 
incubated in a solution containing a mixture of enzymes (0.1% collagenase, 0.2% 
hyaluronidase [H6254; Sigma], 0.04% DNase I [D5025；Sigma], and 0.03% trypsin inhibitor 
[T6522; Sigma] in 1×PBS, pH7.4) at 30 °C for 40 min.  The cells were pelleted and 
subjected to the same hypotonic shock as the interstitial cells, followed by centrifugation and 
RNA extraction of the pellet.  
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Figure Legends 
Fig. 1.  Generation of 15P-1 Sertoli cell clones expressing physiological levels of Rhox5. A, 
Western blot analysis of RHOX5 protein expression in 15P-1 stable clones stably transfected 
with a RHOX5-expression vector.  SL12.4 cells served as positive control for RHOX5 
expression.  Following probing with RHOX5 antiserum, the blot was stripped and reprobed 
with a β-actin antiserum as an internal control for loading.  B, qPCR analysis of total cellular 
RNA from the 15P-1 Sertoli cell clones.  Rhox5 mRNA expression levels in the 15P-1 cell 
clones relative to parental 15P-1 cells (which was arbitrarily given a value of “1”), all 
normalized against ribosomal protein L19 transcript levels.  Adult testis served as a positive 
control.  Values denote the mean fold change ± standard error of mean (SEM).   
 
Fig. 2. Genes regulated by Rhox5 in the adult testis.  qPCR analysis of total cellular RNA 
from adult Rhox5-null (KO) and wild-type (WT) littermate testes.  mRNA levels were 
quantified as described in Fig. 1B.  Statistical analysis was performed using the two-tailed 
Student’s t test: *, p<0.05; **, p<0.01. 
 
Fig. 3.  Cell subset expression pattern of Rhox5-regulated genes.  qPCR analysis of total 
cellular RNA from purified Sertoli and interstitial cells (prepared using hypotonic shock to 
remove germ cells) from adult Rhox5-null (KO) and wild-type (WT) littermate mice testes.  
The value shown for each gene is the average WT/KO mRNA ratio from two independent cell 
preparations, quantified as described in Fig. 1B.  a, mRNA ratios of either >2 or <0.5 (i.e., 
>2-fold change).   
 Fig. 4.  Developmental expression pattern of Rhox5-regulated genes.  qPCR analysis of 
testes RNA from Rhox5-null (KO) and wild-type (WT) littermate mice of the indicated 
postnatal ages (6 mice per time point).  All values were quantified as described in Fig. 1B.  
Postnatal time points at which Rhox5 regulates the indicated genes are denoted by arrows 
(upward and downward arrows indicate genes that are upregulated and downregulated, 
respectively).  A value of “1” was arbitrarily given to the lowest expression level among the 
time points examined for a given gene.  Error bars indicate standard error.  
 
Fig. 5.  Identification of Ar- and Rhox5-regulated genes.  A, qPCR analysis of testes RNA 
from adult Tfm and littermate control mice.  B, qPCR analysis of testes RNA from adult 
Scarko and littermate control mice.  All values were quantified as described in Fig. 1B.  
Control mRNA levels were arbitrarily given a value of “1.”  Statistical analysis was 
performed using the two-tailed Student’s t test: *, p<0.05; **, p<0.01; ***, p<0.001. 
 
Fig. 6.  The candidate SAR gene Unc5c responds to Rhox5 but not Ar and androgen in vitro.   
A, Schematic diagram of Unc5c promoter and Rhox5 proximal promoter (Pp) constructs 
harboring the firefly luciferase (Luc) reporter.  B, Luc expression from MSC1 cells 
transiently cotransfected with pGL3-Unc5c (100 ng), a Renilla luciferase vector (pRL-Tk) (25 
ng) for an internal control, and either a Rhox5-expression vector or the corresponding empty 
expression vector (300 ng).  C, Luc expression from MSC1 cells transiently transfected with 
the constructs shown in panel A (100 ng) and pRL-Tk (25 ng).  Where indicated with 
“+AR,” the cells were cotransfected with an AR expression vector (100 ng).  Where 
indicated with “+T,” the cells were incubated with the synthetic androgen R1881.  The 
relative Luc activities shown are relative to non-treated cells (which were arbitrarily given a 
value of “1”) from three independent transfection experiments.  Error bars indicate standard 
error.  Note that AR + T did not induce endogenous Rhox5 expression in these cells (data not 
shown), explaining why Unc5c expression was not regulated.   
 
Fig. 7.  Regulation of candidate SAR genes by Ar-inducible Rhox genes.  A, qPCR analysis 
of total cellular RNA from 15P-1 Sertoli cells transiently transfected with expression vectors 
encoding the indicated mouse Rhox genes or the empty expression vector (800 ng).  A value 
of “1” was arbitrarily given to the expression of the indicated genes in cells transfected with 
the empty expression vector.  All values were quantified as described in Fig. 1B.  B, Same 
as panel A, except the cells were transiently transfected with expression vectors encoding the 
human RHOXF1 and RHOXF2 proteins.   
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Gene Symbol Gene name Array qPCR Molecular function Celluar component
Tmem47 Transmembrane protein 47 253 519 Signal transduction Membrane
Cd24a CD24a antigen 16.6 15.6 Apoptosis Membrane
Gdap1 Ganglioside-induced differentiation associated protein 1 10.5 4.0 Signal transduction Cytoplasm
Tfrc Transferrin receptor 8.5 2.8 Transport Membrane
Bpgm 2,3-bisphosphoglycerate mutase 3.0 2.7 Metabolism Unknown
Idh3a Isocitrate Dehydrogenase 3 2.6 5.0 Metabolism Mitochondrion
Fzd2 Frizzled homolog 2 -2.1 -2.7 Signal transduction Membrane
Tmem176b Transmembrane protein 176B -2.1 -1.6 Signal transduction Membrane
Tmem176a Transmembrane protein 176A -2.2 -2.2 Unknown Membrane
Bach2 BTB and CNC Homology 2 -2.6 -6.6 Transcription factor Nucleus
Pltp Phospholipid transfer protein -3.2 -5.0 Transport Membrane
Klf9 Kruppel-like factor 9 -3.2 -2.3 Signal transduction Nucleus
Ifnar2 Interferon (alpha and beta) receptor 2 -3.5 -3.2 Signal transduction Membrane
Unc5c Unc5 homolog C -3.5 -9.5 Signal transduction Membrane
Cpxm1 Carboxypeptidase X1 -8.1 -10.3 Transport Extracellular
Table 1. Rhox5 -Regulated Genes
The “Array” column indicates the average change in mRNA level in the Rhox5-positive expressing 
15P-1 Sertoli cell clones (#6 and #24) relative to the Rhox5-negative cell clones (#14 and #16), as 
judged by microarray analysis.  The “qPCR” column lists the average mRNA levels of the same genes, 
as judged using qPCR analysis, normalized against the level of L19 mRNA (see Fig. 1B).  Positive and 
negative values denote gene expression that was upregulated and downregulated, respectively, in 
response to Rhox5.  The genes were classified into “molecular function” and “cellular component”
using OntoExpress software. 
Sertoli Interstitial Sertoli Interstitial Primary
Gene cells cells No-shock No-shock Source
Group 1 Gdap1 2.2 1.0 1.2 1.6 Sertoli
Tfrc 1.9 0.2 0.7 0.5 Sertoli
Tmem176b 2.7 0.4 0.2 0.3 Sertoli
Tmem176a 2.8 0.8 0.3 0.3 Sertoli
Ifnar2 8.3 0.9 0.4 1.4 Sertoli
Group 2 Tmem47 8.9 2.2 2.7 0.1 Sertoli +Interstitial
Fzd2 8.3 6.3 1.7 0.5 Sertoli +Interstitial
Pltp 5.5 4.3 0.9 1.6 Sertoli +Interstitial
Unc5c 1.9 2.0 1.1 1.4 Sertoli+Interstitial
Group 3 Cd24a 0.7 7.7 0.7 1.3 Interstitial
Group 4 Bpgm 0.4 0.7 0.1 0.4 Non-Sertoli/Interstitial
Idh3a 0.9 0.1 1.1 1.1 Non-Sertoli/Interstitial
Bach2 0.5 0.4 0.8 1.1 Non-Sertoli/Interstitial
Klf9 0.8 0.7 1.1 0.9 Non-Sertoli/Interstitial
Cpxm1 0.2 0.04 0.4 0.9 Non-Sertoli/Interstitial
Markers Gata1 4.2 0.1 3.8 0.1 Sertoli
Rhox5 5.3 0.9 1.5 0.2 Sertoli
Lhr 0.6 19.9 0.2 1.0 Interstitial
Tr2 0.7 0.2 1.0 1.9 Germ 
Dazl 0.5 0.1 2.2 1.0 Germ 
Table 2. Cell types expressing Rhox5 - regulated genes
qPCR analysis of total cellular RNA from purified Sertoli and interstitial 
cells obtained from adult testes.  The “no shock” columns refer to the semi-
purified Sertoli and interstitial cell fractions that had not undergone 
hypotonic shock to remove most germ cells.  The numbers are mRNA level 
(normalized against L19 mRNA; see Fig. 1B) in the cell fractions relative
to total testes, the latter of which was arbitrarily given a value of “1.”
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